818 results on '"Tuberculosis, pulmonary"'
Search Results
2. PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) (DECODE)
3. Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia (Core-NB)
4. Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort (INSPIRE-BDLL)
5. Shortened Regimen for Drug-susceptible TB in Children (SMILE-TB)
6. Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
7. Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB (PARADIGM4TB)
8. Linezolid Dosing Strategies in Drug-Resistant TB
9. Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis (PRISM-TB)
10. Integrated Discovery and Development of Innovative TB Diagnostics (CETR)
11. The INSTITUT Study (INSTITUT)
12. Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
13. Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
14. A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers (PaSEM)
15. Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis
16. DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis (DoseTB)
17. Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion (StatinTB)
18. Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis (Doxy-TB)
19. Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis (RAD-TB)
20. A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB
21. Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India
22. Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB)
23. Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) (endTB-Q)
24. Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB (ESCAPE-TB)
25. A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
26. Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection
27. A Clinical Risk Score for Early Management of TB in Uganda (PredicTB)
28. Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
29. Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline (TALF-TB)
30. The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)
31. Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)
32. Airborne Preventive Measures to Reduce New TB Infections in Household Contacts (TBMask)
33. Tuberculosis Research of INA-RESPOND On Drug Resistance (TRIPOD)
34. Comparative Efficacy of CUS, CXR and CAD in TB Diagnosis in LMIC (CUSTB)
35. Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
36. Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
37. Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) (TB-PRACTECAL)
38. Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets (TB-LEOPARD)
39. Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB
40. Clinic-based Versus Hotspot-focused Active TB Case Finding (CHASE-TB)
41. Economic Evaluation of New MDR TB Regimens (PRACTECAL-EE)
42. PanACEA - STEP2C -01
43. Using Biomarkers to Predict TB Treatment Duration
44. Conventional Bronchoscope With BAL vs. Thin Bronchoscope With BW to Diagnose Pulmonary TB
45. VDOT and Mobile Payments in Cambodia
46. INSTI's For The Management of HIV-associated TB (INSIGHT)
47. Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
48. Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis (TB-LUNG)
49. Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (SMA-TB)
50. Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort (INSPIRE-CODA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.